Studies on nimodipine sustained-release tablet capable of floating on gastric fluid with prolonged gastric resident time

Yaoxue Xuebao

Volumn 32, Issue 10, 1997, Pages 786-790

  Wu, W ^a   Zhou, Q ^a   Zhang, H B ^b   Ma, G D ^a   Fu, C D ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b No 208 Hospital of PLA   (China)

Author keywords

Gastric floating tablet; In vitro release; In vivo behavior; Nimodipine; Uniform design

Indexed keywords

DRUG DERIVATIVE; HYDROXYPROPYLMETHYLCELLULOSE; METHYLCELLULOSE; NIMODIPINE;

ARTICLE; BIOAVAILABILITY; DELAYED RELEASE FORMULATION; HUMAN; MALE; METABOLISM; STOMACH JUICE; TABLET;

BIOLOGICAL AVAILABILITY; DELAYED-ACTION PREPARATIONS; GASTRIC JUICE; HUMANS; MALE; METHYLCELLULOSE; NIMODIPINE; TABLETS;

EID: 0031240395     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Langley MS, Sorkin EM. Nimodipine - a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease. Drugs, 1989, 37: 669
2. Sheth PR, Tossounian JL. The hydrodynamically balanced system (HBS™): A novel drug delivery system for oral use. Drug Dev Ind Pharm, 1984, 10:313
3. Tossounian JL, Mergens WJ, Sheth PR. Bioefficient products: A novel delivery system. Drug Dev Ind Pharm, 1985, 11:1019
4. Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci, 1971, 60:1281
5. Krol GJ, Noe AJ, Yeh SC. Gas and liquid chromatographic analyses of nimodipine calcium antagonist in blood plasma and cerebrospinal fluid. J Chromatogr Biomed Appl, 1984, 305:105
6. Mazer N, Abisch E, Gfeller JC, et al. Intragastric behavior and absorption kinetics of a normal and "floating" modified-release capsule of isradipine under fasted and fed conditions. J Pharm Sci, 1988, 77:647
7. Timmermans J, Moes AJ. Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: new data for reconsidering the controversy. J Pharm Sci, 1994, 83:18